As part of the business program of the III International Forum of Pharmaceutical Inspectorates (IFPI), discussions are planned on one of the most pressing topics for the global pharmaceutical community — Good Regulatory Practice (GRP) for medicinal products for human use.
Good Regulatory Practice is a system essential for the effective functioning of national regulatory systems for medicines. It establishes fundamental principles that serve as a guide for prioritising regulatory system functions, taking into account available resources, national plans, public health protection strategies and medicine policies.
GRP was chosen as the main theme of the Forum for specific reason: the dynamic development of the pharmaceutical market — the emergence of new drug classes, technological advances and the distribution of medicine production across different countries — poses new challenges for regulators. Regulatory authorities need to build efficient, predictable and transparent processes for the industry.
During the Forum's plenary session, "Good Regulatory Practice: Harmonisation and Strengthening of Regulatory Systems for Medicinal Products”, participants will be introduced to the experience of different countries and the position of WHO experts, as well as discuss how to adapt best GRP practices to their own jurisdictions — from procedural transparency to engaging industry representatives in regulatory dialogue.
At the session "Good Regulatory Practice: Modern Approaches", international experts will discuss transparency, engagement and predictability of regulatory processes.
The III International Forum of Pharmaceutical Inspectorates will take place on 16–17 November 2026 in Hanoi, Vietnam.
IFPI organizers are giving Forum participants the opportunity to ask questions to the speakers.*
Please submit your questions—the moderator will pose the most interesting ones to the speakers during the session. This is a great opportunity to get direct feedback from experts and influence the direction of the discussion.
You can submit your question via email to info@ifpi-forum.com or via WhatsApp.
*Only participants who have registered for the Forum may ask questions of the speakers
Good Regulatory Practice is a system essential for the effective functioning of national regulatory systems for medicines. It establishes fundamental principles that serve as a guide for prioritising regulatory system functions, taking into account available resources, national plans, public health protection strategies and medicine policies.
GRP was chosen as the main theme of the Forum for specific reason: the dynamic development of the pharmaceutical market — the emergence of new drug classes, technological advances and the distribution of medicine production across different countries — poses new challenges for regulators. Regulatory authorities need to build efficient, predictable and transparent processes for the industry.
During the Forum's plenary session, "Good Regulatory Practice: Harmonisation and Strengthening of Regulatory Systems for Medicinal Products”, participants will be introduced to the experience of different countries and the position of WHO experts, as well as discuss how to adapt best GRP practices to their own jurisdictions — from procedural transparency to engaging industry representatives in regulatory dialogue.
At the session "Good Regulatory Practice: Modern Approaches", international experts will discuss transparency, engagement and predictability of regulatory processes.
The III International Forum of Pharmaceutical Inspectorates will take place on 16–17 November 2026 in Hanoi, Vietnam.
IFPI organizers are giving Forum participants the opportunity to ask questions to the speakers.*
Please submit your questions—the moderator will pose the most interesting ones to the speakers during the session. This is a great opportunity to get direct feedback from experts and influence the direction of the discussion.
You can submit your question via email to info@ifpi-forum.com or via WhatsApp.
*Only participants who have registered for the Forum may ask questions of the speakers